Navigation Links
MIT material stops bleeding in seconds

ase, the self-assembling peptides served as an internal matrix on which brain cells could regrow.

While experimenting with the liquid during brain surgery, the researchers discovered that some of the peptides could also stop bleeding, Ellis-Behnke said. He foresees that the material could be of great use during surgery, especially surgery that is done in a messy environment such as a battlefield. A fast and reliable way to stop bleeding during surgery would allow surgeons better access and better visibility during the operation.

"The time to perform an operation could potentially be reduced by up to 50 percent," said Ellis-Behnke.

Unlike some methods now used for hemostasis, the new materials can be used in a wet environment. And unlike some other agents, it does not induce an immune response in the animals being treated.

When the solution containing the peptides is applied to bleeding wounds, the peptides self-assemble into a gel that essentially seals over the wound, without harming the nearby cells. Even after excess gel is removed, the wound remains sealed. The gel eventually breaks down into amino acids, the building blocks for proteins, which can be used by surrounding cells.

The exact mechanism of the solutions' action is still unknown, but the researchers believe the peptides interact with the extracellular matrix surrounding the cells. "It is a completely new way to stop bleeding; whether it produces a physical barrier is unclear at this time," Ellis-Behnke said.

The researchers are confident, however, that the material does not work by inducing blood clotting. Clotting generally takes at least 90 seconds to start, and the researchers found no platelet aggregation, a telltale sign of clotting.

Other MIT researchers who are co-authors on the paper are Gerald Schneider, professor of brain and cognitive sciences, and Shuguang Zhang, associate director of MIT's Center for Biomedical Engineering. C
'"/>

Source:Massachusetts Institute of Technology


Page: 1 2 3

Related biology news :

1. Purdue proves concept of using nano-materials for drug discovery
2. UCLA scientists store materials in cells natural vaults
3. Engineers improve plastics potential for use in implants by linking it to biological material
4. FDA approves first medical device using rutgers biomaterial
5. Corals switch skeleton material as seawater changes
6. Blood-compatible nanoscale materials possible using heparin
7. Finding the right mix: A biomaterial blend library
8. Nanotextured implant materials: blending in, not fighting back
9. Intelligent materials to regenerate bone tissue
10. One bacteria stops another on contact
11. Anthrax stops body from fighting back, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: MIT material stops bleeding seconds

(Date:3/14/2010)... A large study from Children,s Hospital Boston and the ... samples the entire genome, known as chromosomal microarray analysis, ... changes related to autism spectrum disorders (ASDs) than standard ... (and online March 15), the authors urge that ... ASDs. , Expectant parents who have family members ...
(Date:3/14/2010)... March 10, 2010 Using a novel light activation ... turn molecules with only a modest ability to fight ... technique, which uses a "warhead" molecule capable of inactivating ... accelerate the development of new therapies by providing researchers ... , The study was published March 14, 2010 ...
(Date:3/14/2010)... For two decades, scientists have been pursuing a ... naturally occurring proteins known as antimicrobial peptides (AMPs). ... images showing the deadly effects of AMPs, most ... cell membranes. , Researchers in the laboratory of ... sensitive technique known as high-speed atomic force microscopy ...
Breaking Biology News(10 mins):A better genetic test for autism 2A better genetic test for autism 3Light activated 'warhead' turns modest molecules into super protein killers 2Light activated 'warhead' turns modest molecules into super protein killers 3New microscopy technique offers close-up, real-time view of cellular phenomena 2UC Riversides new state of the art technology to accelerate stem cell research 11667 1UC Riversides new state of the art technology to accelerate stem cell research 11667 2Lifestyle changes for teens critical in light of research about teens heart disease risk 11664 1Lifestyle changes for teens critical in light of research about teens heart disease risk 11664 2Fat Burning Chemical Points to New Weight Loss Drug 65716 1
... media coverage of nanotechnologys potential risks growing" ... in national newspapers and newswiresenvironmental and consumer organizations, ... How do broadcast journalists decide to cover a ... Do radio and television correspondents face special challenges ...
... new method developed in Britain over the past 17 years ... to exploit a massive heavy oilfield in Canada. , ... (THAI™) system developed at the University of Bath at its ... light oil, heavy oil is very viscous, like syrup, or ...
... the Health Care Industry, SAN JOSE, Calif., ... TTNUF), a leading biometric and security solutions,provider announced ... Kong,Polytechnic University Clinic for the installation of a ... technology. In,this newly designed application, all patients, together ...
Other Biology News:Nanotechnology and the media: The inside story 2Massive Canadian oilfield could be exploited using new UK system 2Massive Canadian oilfield could be exploited using new UK system 3Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong 2Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong 3
(Date:3/11/2010)... US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1).  Additional claims cover ... ... , ... ... ...
(Date:3/11/2010)... for Advanced Micro Nano Technology Products (ACAMP) hosts Conventional Energy seminar , ... , ... ... ... EDMONTON , March 11 /PRNewswire/ - Today at ACAMP,s latest seminar, ...
(Date:3/11/2010)... 11 Advanced Life Sciences ... biopharmaceutical company engaged in the discovery, development ... therapeutic areas of infection, oncology and respiratory ... and Drug Administration (FDA) has provided guidance ... the approvability of Restanza™ (cethromycin), a novel ...
(Date:3/10/2010)... plants is the most important technological innovation during ... has occurred as humans have used individuals carrying ... current issue of Nature an international ... revealed some of the secrets underlying the remarkable ... chicken has in recent years become the most ...
Breaking Biology Technology:Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 2Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 3Alberta companies delivering new products to the Conventional Energy marketplace 2Alberta companies delivering new products to the Conventional Energy marketplace 3Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 2Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 3Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 4Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 5Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 6Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 7Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 8Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications 9Scientific breakthrough in genetic studies of animal domestication 2
... FRANCISCO, Calif., Oct. 23 Poniard,Pharmaceuticals, Inc. (Nasdaq: ... today announced that it will hold a conference ... provide a corporate update,including an update on the ... candidate., Jerry McMahon, Ph.D., chairman and chief ...
... ARNA ) today announced it will report third ... on Thursday,October 30, 2008. That same afternoon, Jack Lief, ... Arena,s Vice President,Finance and Chief Financial Officer, will host ... Pacific Time) to discuss the third quarter,2008 financial results ...
... for October 31, 2008 at 11:00 am EASTERN, ... TRIB ), a leading developer and manufacturer of diagnostic ... results for the third quarter of fiscal year 2008 ... conference call for that same,day, Friday, October 31, 2008, ...
Other Biology Technology:Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference Call on October 30 2Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008 2Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008 3Trinity Biotech plc to Announce Third Quarter 2008 Financial Results on October 31, 2008 2
MAB3246 recognizes the neuro-endocrine specific protein (NSP) C....
Rat integrin a6b1, mainly associated with epithelial cells. Does not react with rat fibroblasts....
Mouse monoclonal [4i144] to HLA Class II DQ1 7 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 2 Antigen DQ1,7....
ANXA11 Immunogen: ANXA11 (NP_001148, 406 a.a. ~ 506 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: